A Brave New World: The Clinical Management of Bone Marrow Failure and Myeloid Malignancy in a Time of Personalized Therapy
Friday, December 8, 2017 – 12:30-4:30 pm
Marriott Marquis Atlanta, Symposium Room A703 – A704
Satellite Symposium organized by the Cleveland Clinic Taussig Cancer Institute Leukemia Program and the Aplastic Anemia and MDS International Foundation, preceding the 59th ASH Annual Meeting.
The complimentary symposium will provide an in-depth and up-to-date review of research related to the biology, prognosis, natural history, and therapeutic management of patients with aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). The program will bring leaders in disease research and clinical practice together to explore solutions to improve the care of patients.
Regional Bone Marrow Failure Disease Symposia
Nashville, TN - October 13, 2017
Cosponsored with Vanderbilt Univeristy Medical Center
Vanderbilt University Medical Center and the Aplastic Anemia and MDS International Foundation are jointly presenting this symposium to provide the latest information on the diagnosis and management of bone marrow failure disease and myeloid malignancies according to current clinical practice guidelines and recent research findings. The expert faculty will provide unique insight into these rare conditions and provide systematic approaches to clinical practice.